Which pill do patients prefer? study lets them choose

NCT ID NCT00905047

First seen Mar 17, 2026 · Last updated May 12, 2026 · Updated 7 times

Summary

This study looked at two oral chemotherapy drugs, Xeloda and UFT with folinic acid, for people with advanced or metastatic colorectal cancer. The main goal was to find out which treatment patients preferred after trying both. The study also checked how safe each drug was. 89 adults took part, and the results help doctors understand patient preferences when choosing between these treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre Hospitalier

    Armentières, 59280, France

  • Centre Hospitalier

    Roubaix, 59100, France

  • Centre Hospitalier

    Valenciennes, 59300, France

  • Centre Hospitalier Regional

    Lille, 59035, France

  • Centre Hospitalier de Béthune

    Beuvry, 62660, France

  • Centre Hospitalier de CHOLET

    Cholet, 49300, France

  • Centre Joliot-Curie

    Saint Martin Les Boulogne, 62280, France

  • Centre Leonard de Vinci

    Dechy, 59187, France

  • Centre Oscar Lambret

    Lille, 59020, France

  • Centre Paul Papin

    Angers, 49033, France

  • Clinique des Dentellieres

    Valenciennes, 59300, France

  • Hopital Saint Vincent de Paul

    Lille, 59020, France

  • Polyclinique du Bois

    Lille, 59000, France

Conditions

Explore the condition pages connected to this study.